Evidence map›Paper›PMID 30297674›Full record

ArticlePharmaceutics2018

Fabrication and Characterization of Strontium-Substituted Hydroxyapatite-CaO-CaCO₃ Nanofibers with a Mesoporous Structure as Drug Delivery Carriers.

Shiao-Wen Tsai, Wen-Xin Yu, Pai-An Hwang, Sheng-Siang Huang, Hsiu-Mei Lin, Yu-Wei Hsu, Fu-Yin Hsu

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Harnessing strontium in regenerative dentistry: progress and perspectives.Frontiers in bioengineering and biotechnology · 2025
    Review
  4. Applications of Bioactive Strontium Compounds in Dentistry.Journal of functional biomaterials · 2024
    Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Shiao-Wen TsaiGraduate Institute of Biomedical Engineering, Chang Gung University, Taoyuan City 33302, Taiwan. swtsai@gap.cgu.edu.tw.ORCID 0000-0002-6225-6613
Wen-Xin YuDepartment of Bioscience and Biotechnology, National Taiwan Ocean University, Keelung City 20224, Taiwan. andy54861@yahoo.com.tw.
Pai-An HwangDepartment of Bioscience and Biotechnology, National Taiwan Ocean University, Keelung City 20224, Taiwan. amperehwang@ntou.edu.tw.
Sheng-Siang HuangDepartment of Bioscience and Biotechnology, National Taiwan Ocean University, Keelung City 20224, Taiwan. mm0070360@gmail.com.
Hsiu-Mei LinDepartment of Bioscience and Biotechnology, National Taiwan Ocean University, Keelung City 20224, Taiwan. hmlin@mail.ntou.edu.tw.
Yu-Wei HsuDepartment of Bioscience and Biotechnology, National Taiwan Ocean University, Keelung City 20224, Taiwan. qazwest74@gmail.com.
Fu-Yin HsuDepartment of Bioscience and Biotechnology, National Taiwan Ocean University, Keelung City 20224, Taiwan. fyhsu@mail.ntou.edu.tw.ORCID 0000-0002-8221-4218
National Taiwan Ocean University · TWChang Gung University · TW

Funding

Ministry of Science and Technology, Taiwan 105-2221-E-019-008 and 106-2221-E-019 -021 -MY2
6 · The paper itself

Abstract

Hydroxyapatite (HAp) is the main inorganic component and an essential part of hard bone and teeth. Due to its excellent biocompatibility, bioactivity, and osteoconductivity, synthetic HAp has been widely used as a bone substitute, cell carrier, and therapeutic gene or drug carrier. Recently, numerous studies have demonstrated that strontium-substituted hydroxyapatite (SrHAp) not only enhances osteogenesis but also inhibits adipogenesis in mesenchymal stem cells. Mesoporous SrHAp has been successfully synthesized via a traditional template-based process and has been found to possess better drug loading and release efficiencies than SrHAp. In this study, strontium-substituted hydroxyapatite-CaO-CaCO₃ nanofibers with a mesoporous structure (mSrHANFs) were fabricated using a sol⁻gel method followed by electrospinning. X-ray diffraction analysis revealed that the contents of CaO and CaCO₃ in the mSrHANFs decreased as the doping amount of Sr increased. Scanning electron microscopy (SEM) images showed that the average diameter of the mSrHANFs was approximately 200~300 nm. The N₂ adsorption⁻desorption isotherms demonstrated that the mSrHANFs possessed a mesoporous structure and that the average pore size was approximately 20~25 nm. Moreover, the mSrHANFs had excellent drug- loading efficiency and could retard the burst release of tetracycline (TC) to maintain antibacterial activity for over 3 weeks. Hence, mSrHANFs have the potential to be used as drug carriers in bone tissue engineering.

Indexed as

drug deliveryhydroxyapatitemesoporousstrontium

Identifiers

PMID30297674
PMCPMC6321556
OpenAlexW2895279760

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.